Because of IL-8's critical involvement in lung disease aetiology and inflammation, it may be conceivable to use IL-8 as a new therapeutic target to effectively control the hyperinflammatory response in ARDS [19]. Here, CXCL8 is linked to acute respiratory distress syndrome.